JD Health International Inc. (HKG:6618)
Hong Kong · Delayed Price · Currency is HKD 55.95
+2.05 (3.80%)
Aug 13, 2025, 4:08 PM HKT
JD Health International Market Cap
JD Health International has a market cap or net worth of 172.49 billion as of August 12, 2025. Its market cap has increased by 163.16% in one year.
Market Cap
172.49B
Enterprise Value
118.25B
Revenue
61.89B
Ranking
n/a
PE Ratio
38.37
Stock Price
55.95
Market Cap Chart
Since December 8, 2020, JD Health International's market cap has decreased from 343.98B to 172.49B, a decrease of -49.86%. That is a compound annual growth rate of -13.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 172.49B | 91.91% |
| Dec 31, 2024 | 89.88B | -27.91% |
| Dec 29, 2023 | 124.67B | -45.05% |
| Dec 30, 2022 | 226.89B | 15.58% |
| Dec 31, 2021 | 196.31B | -58.90% |
| Dec 31, 2020 | 477.66B | 38.86% |
| Dec 8, 2020 | 343.98B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.91B |
| Hansoh Pharmaceutical Group Company | 210.36B |
| Innovent Biologics | 156.29B |
| Akeso | 143.97B |
| Sino Biopharmaceutical | 131.63B |
| WuXi Biologics | 119.51B |
| CSPC Pharmaceutical Group | 117.30B |
| Sichuan Kelun-Biotech Biopharmaceutical | 92.10B |